Capital Performance Advisors’s MetLife MET Stock Holding History

Capital Performance Advisors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-732	Closed	-$60.3K	–	1645
2024 Q3	$60.3K	Buy	+732	New	+$54.7K	0.02%	302

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Performance Advisors's MET Position: Q4 2024 in Review

Capital Performance Advisors sold out of MetLife (MET) in Q4 2024, closing a stake of 732 shares — an estimated $60.3K sold.

Capital Performance Advisors first reported a position in MET in Q3 2024 and held it in 1 quarter. The position peaked at $60.3K in Q3 2024. 1,401 funds tracked by Wall St. Rank hold MET as of Q4 2024.

Capital Performance Advisors reported no remaining MetLife position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 732 MetLife shares in Q4 2024, an estimated $60.3K.
Capital Performance Advisors first reported a position in MetLife in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's MetLife position peaked at $60.3K in Q3 2024.
1,401 funds tracked by Wall St. Rank held MetLife as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.